MUC1 and idiopathic pulmonary fibrosis: This preliminary population is of interest because higher KL-6 concentrations were recorded in IPF-LC patients than in the IPF and fHP groups, demonstrating that KL-6 may be a useful prognostic biomarker, predictive of IPF progression.